The Accreditation Committee of the College of American Pathologists (CAP) awarded accreditation to the National Disease Research Interchange (NDRI)’s Biorepository based on results of a recent on-site inspection conducted by CAP inspectors. The inspection team included practicing pathology and laboratory medicine professionals. Recognized for rigorous and robust standards, CAP accreditation elevates quality and mitigates risk, an important way that laboratories can contribute to improved patient outcomes.
The facility’s director, Melissa VonDran, PhD, QBRS(ASCP) was advised of this global recognition and congratulated the laboratory for its excellence in the services being provided. NDRI is one of more than 8,000 CAP-accredited facilities worldwide.
“NDRI is committed to maintaining the highest standards in human tissue recovery, storage, and distribution, as shown by our recent CAP accreditation. Compliance with CAP’s biorepository standards ensures that we contribute to our mission of advancing biomedical research worldwide and honor the donated gifts from donors and their families”, said Dr. VonDran.
During the CAP accreditation process inspectors examine the laboratory’s records and quality control of procedures. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management. These reviews help verify activities reflect the most recent best practices.
NDRI has participated in the CAP accreditation program for biorepositories since 2016.
About the College of American Pathologists
As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, visit the CAP Newsroom, CAP.org and yourpathologist.org to watch pathologists at work and see the stories of the patients who trust them with their care.
About NDRI
The National Disease Research Interchange (NDRI) is the nation’s leading source of human tissues, cells and organs for scientific research. A not-for-profit 501 (c) (3) organization founded in 1980, NDRI is funded in part by the National Institutes of Health, public and private foundations and organizations, pharmaceutical and biotechnology corporations. NDRI is a 24/7 operation that partners with a nationwide network of over 130 tissue source sites (TSS), including organ procurement organizations (OPOs), tissue banks, eye banks, and hospitals. The TSS, are distributed throughout the USA, in 45 states, with concentrations in major metropolitan areas on both the east and west coasts. Their wide geographic distribution allows NDRI to provide biospecimens from donor populations with diverse demographics and facilitates the timely and efficient provision of fresh tissues directly to researchers across the U.S. and around the world. By serving as the liaison between procurement sources and the research community, NDRI is uniquely positioned to support breakthrough advances and discoveries that can affect advances in the treatment and cure of human diseases.